Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SciSparc
Recent news which mentions SciSparc
SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 22, 2023
Tickers
BIDU
DE
EVS
MARA
Tags
Benzinga
SPRC
BIDU
From
Benzinga
SciSparc Signs LOI to Sell 50% Interest in Subsidiary
December 15, 2022
Tickers
JFBR
SPRC
Tags
Market News
SciSparc
Penny Stocks
From
Benzinga
Can This Company's Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?
November 15, 2022
Tickers
AMPH
Tags
Cannabis
Market News
Markets
From
Benzinga
SciSparc Nutraceuticals Signs Agreement With Logistics Facilities, Expected To Optimize Handling and Shipment Processes and Reduce Direct Sales Costs
November 02, 2022
Tickers
SPRC
Tags
News
SciSparc
Benzinga
From
Benzinga
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
September 14, 2022
Tickers
SPRC
Tags
SciSparc
Press Releases
Benzinga
From
Benzinga
Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration
August 25, 2022
Tickers
CMNDF
SPRC
Tags
Biotech
SPRC
Penny Stocks
From
Benzinga
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
August 25, 2022
Tickers
CMNDF
SPRC
Tags
Partner Content
Market News
CMNDF
From
Benzinga
Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know
August 24, 2022
Tickers
CMNDF
SPRC
Tags
SciSparc
Clearmind Medicine
Markets
From
Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
August 12, 2022
Tickers
SPRC
Tags
Press Releases
SciSparc
SPRC
From
Benzinga
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
July 20, 2022
Tickers
BIIB
LLY
PFE
SAVA
Tags
BIIB
SciSparc
Market News
From
Benzinga
SciSparc Announces Buyback Equal To 12% Of Float
July 07, 2022
Tickers
SPRC
Tags
Market News
Partner Content
Buybacks
From
Benzinga
SciSparc Completes Development Of Its Proprietary Drug Candidate SCI-110 To Treat Tourette Syndrome
June 30, 2022
Tickers
SPRC
Tags
News
Biotech
SPRC
From
Benzinga
SciSparc Successfully Completed The Development Of Its Proprietary Drug Candidate SCI-110 For Its Upcoming Phase IIb Study In Tourette Syndrome
June 29, 2022
Tickers
SPRC
Tags
Partner Content
Benzinga
Penny Stocks
From
Benzinga
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
June 28, 2022
Tickers
ABC
CAH
JNJ
MCK
Tags
JNJ
Health Care
Penny Stocks
From
Benzinga
SciSparc Receives Ethics Committee Approval To Conduct Clinical Trial In ASD With Proprietary SCI-210 Treatment
June 24, 2022
Tickers
SPRC
Tags
Partner Content
Market News
SciSparc
From
Benzinga
SciSparc Announces Ethics Committee Approval To Conduct Its Clinical Trial In Autism Spectrum Disorder
June 23, 2022
Tickers
SPRC
Tags
SPRC
Biotech
Benzinga
From
Benzinga
SciSparc Reinforces Its New JV For Targeting Discovery With A Global Expert In The Field Of Mitochondrial Transport Proteins
June 15, 2022
Tickers
SPRC
Tags
General
SciSparc
Partner Content
From
Benzinga
Initial Positive Results For Cocaine Addiction Treatment Announced
June 08, 2022
Tickers
SPRC
Tags
SciSparc
General
Partner Content
From
Benzinga
SciSparc Ltd. Announces Initial Positive Results For The Cocaine Addiction Treatment Of Clearmind Medicine Inc.
June 07, 2022
Tickers
CMNDF
SPRC
Tags
Partner Content
CMNDF
Market News
From
Benzinga
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
June 02, 2022
Tickers
CMNDF
SPRC
Tags
Biotech
SPRC
Benzinga
From
Benzinga
SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems
May 31, 2022
Tickers
SPRC
Tags
Penny Stocks
Benzinga
SPRC
From
Benzinga
SciSparc Gets Ethics Committee Approval In Germany And Israel Sites To Conduct A Phase IIb Trial In Tourette Syndrome
May 27, 2022
Tickers
SPRC
Tags
General
SciSparc
Market News
From
Benzinga
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial In Tourette Syndrome
May 26, 2022
Tickers
SPRC
Tags
Market News
Partner Content
SciSparc
From
Benzinga
Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients
May 25, 2022
Tickers
JNJ
RDY
SPRC
Tags
Cryptocurrency
SPRC
Penny Stocks
From
Benzinga
SciSparc And Clearmind Medicine Inc. Collaboration Yields Positive Results For Its Psychedelic Combination Treatment
May 24, 2022
Tickers
SPRC
Tags
Market News
Markets
Partner Content
From
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Tickers
ABC
JNJ
SPRC
Tags
SPRC
Psychedelics
Benzinga
From
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Tickers
ABC
JNJ
SPRC
Tags
SciSparc
ABC
Market News
From
Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
May 17, 2022
Tickers
SPRC
Tags
Penny Stocks
Benzinga
Biotech
From
Benzinga
Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested
May 13, 2022
Tickers
CMNDF
SPRC
Tags
CMNDF
Cannabis
Market News
From
Benzinga
The Hidden Potential Of The Endocannabinoid System? SciSparc Says Its Portfolio Of Cannabinoids-Derived Drug Candidates Tap The Body's Natural System
May 12, 2022
Tickers
SPRC
Tags
SPRC
Penny Stocks
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit